MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
AdaptHealth Corp. EV - Enterprise Value 2011-2026 | AHCO
Annual EV - Enterprise Value AdaptHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.89 B | 4.23 B | 4.33 B | 5.14 B | 5.42 B | 3.33 B | 1.49 B | 318 M | 166 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.42 B | 166 K | 3.13 B |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B |  USA |
 |
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
33.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | USA |
 |
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-1.67 M | - | 1.37 % | $ 20.5 M | USA |
 |
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | USA |
 |
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | USA |
 |
Cytosorbents Corporation
CTSO
|
66.9 M | $ 0.62 | -1.31 % | $ 38.6 M | USA |
 |
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.22 | - | $ 121 M |  France |
 |
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
340 M | $ 11.67 | -0.98 % | $ 330 M | USA |
 |
Globus Medical
GMED
|
12.7 B | $ 95.25 | 0.39 % | $ 12.9 B | USA |
 |
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | USA |
 |
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | USA |
 |
Electromed
ELMD
|
170 M | $ 26.39 | -0.34 % | $ 223 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.7 M | $ 2.28 | 5.56 % | $ 1.39 M | USA |
 |
Second Sight Medical Products
EYES
|
7.43 M | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | USA |
 |
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
639 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
579 M | $ 16.41 | 1.36 % | $ 385 M | USA |
 |
Butterfly Network
BFLY
|
765 M | $ 5.33 | -0.09 % | $ 1.13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | USA |
 |
LivaNova PLC
LIVN
|
4.58 B | $ 63.87 | -0.51 % | $ 3.48 B |  Britain |
 |
LENSAR
LNSR
|
142 M | $ 5.08 | -0.2 % | $ 60.7 M | USA |
 |
Pulmonx Corporation
LUNG
|
78.3 M | $ 1.28 | 0.79 % | $ 52.1 M | USA |
 |
Delcath Systems
DCTH
|
295 M | $ 10.97 | 1.2 % | $ 393 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.8 M | $ 1.09 | 2.83 % | $ 18.5 M | USA |
 |
CONMED Corporation
CNMD
|
2.57 B | $ 39.18 | 2.08 % | $ 1.22 B | USA |
 |
Inspire Medical Systems
INSP
|
1.78 B | $ 55.85 | -0.75 % | $ 1.64 B | USA |
 |
Insulet Corporation
PODD
|
19.1 B | $ 191.14 | 0.83 % | $ 13.4 B | USA |
 |
Integer Holdings Corporation
ITGR
|
4.62 B | $ 85.95 | -0.06 % | $ 2.99 B | USA |
 |
PAVmed
PAVM
|
20.8 M | $ 9.11 | 1.22 % | $ 6.11 M | USA |
 |
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
49.3 B | $ 83.94 | -0.37 % | $ 49.1 B | USA |
 |
Sintx Technologies
SINT
|
9.34 M | $ 2.43 | -1.62 % | $ 6.74 M | USA |
 |
MiMedx Group
MDXG
|
699 M | $ 3.46 | 0.87 % | $ 511 M | USA |
 |
Stryker Corporation
SYK
|
21.4 B | $ 328.6 | 0.34 % | $ 126 B | USA |
 |
Tactile Systems Technology
TCMD
|
611 M | $ 25.34 | 1.08 % | $ 580 M | USA |
 |
Nevro Corp.
NVRO
|
441 M | - | - | $ 217 M | USA |